Ben-Aharon, Irit <br/><br/>
Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  Sep 2014 
 - 1230-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.3109/0284186X.2014.934397  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ambulatory Care<br/>Cause of Death<br/>Fibrinolytic Agents--therapeutic use<br/>Hemorrhage--chemically induced<br/>Heparin, Low-Molecular-Weight--therapeutic use<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Neoplasms--drug therapy<br/>Pancreatic Neoplasms--etiology<br/>Primary Prevention<br/>Pulmonary Embolism--etiology<br/>Randomized Controlled Trials as Topic<br/>Venous Thromboembolism--etiology<br/>Venous Thrombosis--etiology